Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Charles Barkley is going on the offense after seeing his weight rebound. | Charles Barkley is going on the offense after ...

Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy ...

Currently Wegovy has a list price of around $1,350 for a 28-day supply. This means that the medication could cost more than ...

Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...

About Hims & Hers Health Inc. Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for ...

The results of the 2024 HIMSS Healthcare Cybersecurity Survey was recently published in the first quarter of 2025. Respondents to this survey included cybersecurity professionals of healthcare ...

Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season. The 9 healthcare technology stocks we ...

1 Day HIMS -8.52% DJIA -1.73% S&P 500 -2.24% Retail/Wholesale 0.13% ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the ...

Hims & Hers Health’s shares are extremely volatile and have had 87 moves greater than 5% over the last year. But moves this big are rare even for Hims & Hers Health and indicate this news ...